Invesco Exchange-Traded Self-Indexed Fund Trust has released its financial results for the period ending August 31, 2026, showing a total asset value of approximately $27 million. This update is significant as it highlights the company's position in the investment sector, particularly within the exchange-traded fund (ETF) market.
Invesco Exchange-Traded Self-Indexed Fund Trust is an investment entity based in Downers Grove, Illinois. As per the SEC filings, the company operates under the Central Index Key (CIK) number 0001657201. The firm was previously known as PowerShares Exchange-Traded Self-Indexed Fund Trust until its name change in October 2015. It focuses on managing exchange-traded funds, which are popular among investors for their liquidity and diversification benefits.
The recent filing, with accession number 0001657201-26-000783, indicates that the total assets reported as of August 31, 2026, stand at $27,040,133.63, with total liabilities of $346,227.13, resulting in net assets of $26,693,906.50. The filing also includes information on the fund's investment strategies and performance metrics.
In terms of impact, this filing may affect various stakeholders, including investors looking for insights into the performance of Invesco's funds. The reported figures could influence investment decisions and perceptions of the ETF market. Additionally, the filing highlights the competitive landscape where Invesco operates, with firms like BNP Paribas and Aflac also vying for investor interest in similar financial products.
Looking ahead, the filing does not specify any immediate next steps or upcoming events related to these results. However, investors and analysts will likely monitor future filings for trends and additional insights into the fund's performance and strategies.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






